Voiding Disorders Clinical Trial
Official title:
Urodynamically Age-specific Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Voiding Dysfunction Without Cystocele
Women with symptoms of voiding dysfunction may be associated with detrusor underactivity (DU) or bladder outlet obstruction (BOO). The treatment strategies are different between DU and BOO. In general, urodynamic/videourodynamic studies are important for differential diagnosis. However, urodynamic/videourodynamic studies are invasive. The investigators are interested in whether there were specific symptoms or measurements that can be used for initial differential diagnosis between DU and BOO. Thus, the aim of this study was to elucidate the prevalence of DU and BOO in each age group and elucidate the clinical and urodynamic differences between the DU, BOO and non-DU/BOO groups.
Between April 1996 and September 2018, all women with symptoms of voiding dysfunction who
visited the urogynecological department of a medical center for urodynamic evaluation were
reviewed. Those women who have no complete data of maximum flow rate (Qmax), voided volume,
post-void residual volume (PVR) and detrusor pressure at a maximum flow rate (PdetQmax) were
excluded from this study. Besides, women with cystocele were also excluded. The DU was
defined when the PdetQmax was less than 20 cmH2O, the Qmax was less than 15 mL/s, and the
bladder voiding efficiency (BVE) was less than 90 %. The BOO was defined when the PdetQmax
was not less than 40 cmH2O, and the Qmax was less than 12 mL/s. BVE = voided volume / (voided
volume+ PVR) x 100%. Those women without DU or BOO were allocated to the non-DU/BOO group.
STATA software was used for statistical analysis. ANOVA test with Bonferroni correction or
chi-square test was used for statistical analysis as appropriate. Linear regression analysis
with age adjustment was used to assess the adjusted effect of variables. P < 0.05 was
considered as statistical significant.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04010656 -
Optimization of Spontaneous Postoperative Trial of Void Among Women
|
N/A | |
Enrolling by invitation |
NCT05537272 -
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
|
Phase 4 | |
Recruiting |
NCT06070675 -
Comparison of a Paper and Automated Bladder Diary in Pediatric Patients
|
N/A | |
Completed |
NCT03141372 -
Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial
|
N/A | |
Completed |
NCT03373773 -
Home vs. Office Foley Catheter Removal in Women With Voiding Difficulty Following Pelvic Reconstructive Surgery
|
N/A | |
Recruiting |
NCT05490082 -
Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation
|
Phase 3 | |
Recruiting |
NCT04429360 -
What is the Effect of Prolapse Surgery on Voiding?
|
||
Completed |
NCT03991429 -
Brain Imaging in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05182853 -
Voiding Disorders in Children After Sacrococcygeal Teratoma Resection
|
||
Completed |
NCT05941260 -
Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
|
||
Completed |
NCT03390790 -
Lidocaine for Pain After Urodynamic Testing
|
Phase 4 | |
Completed |
NCT04928716 -
Multiple Sclerosis and Voiding Symptoms: How to Assess?
|
||
Completed |
NCT04064619 -
Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms
|
N/A | |
Not yet recruiting |
NCT05240456 -
Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children
|
Phase 1/Phase 2 | |
Recruiting |
NCT03293771 -
Transgender Post-reassignment Urogynecologic Measures and Perceptions
|
||
Completed |
NCT03631160 -
Effect of Transcutaneous Acupoint Electrical Stimulation on Postoperative Spontaneous Voiding for Laparoscopic Patients
|
N/A | |
Completed |
NCT05295823 -
Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound
|
N/A | |
Completed |
NCT04570605 -
Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population
|
N/A |